StethoMe Revenue and Competitors

poznań,

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • StethoMe's estimated annual revenue is currently $2.6M per year.(i)
  • StethoMe's estimated revenue per employee is $98,000

Employee Data

  • StethoMe has 27 Employees.(i)
  • StethoMe grew their employee count by -13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M4N/AN/AN/A
#2
$3.4M307%N/AN/A
#3
$27M17526%N/AN/A
#4
$7.7M610%N/AN/A
#5
$175.6M877-6%$91.2MN/A
#6
$1.5M18-5%N/AN/A
#7
$2M20N/AN/AN/A
#8
$0.2M3-70%N/AN/A
#9
$32M20841%N/AN/A
#10
$1.3M16-33%N/AN/A
Add Company

What Is StethoMe?

StethoMe®, an AI startup focussed on the world of healthcare and telemedicine. The StethoMe® solution is the first system that detects abnormalities in children's lungs, helping parents to monitor their kids' asthma. It relies on medical AI algorithms (CE 2274) working together with a wireless, electronic stethoscope and dedicated application. StethoMe® is intended for home use by patients. How does it work? The stethoscope records the sounds from your kids' lungs. These sounds are immediately analyzed by AI algorithms providing you with instant feedback of any abnormal sounds detected in the lungs. Thanks to this unique technology you can easily control your kid's condition at home and in case needed to contact your doctor using telemedicine. The device and AI algorithms are professional medical devices. Safe to use by patients at home. Both are certified in the EU as a class 2a medical device (CE 2274).

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.6M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

StethoMe News

2022-04-20 - Warsaw-based Doctor.One picks up €2.1 million for its virtual ...

... including Vue Storefront, Packhelp and StethoMe, has made a follow-on investment in the startup, after being the first to believe in the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M284%N/A
#2
$5.4M333%N/A
#3
$9.5M36-14%N/A
#4
$4.4M37-10%N/A
#5
$10.5M4018%N/A